ENTERIC COATED LEVODOPA FOR THE MEDICAL MANAGEMENT OF PARKINSONISM

Abstract

Enteric coated levodopa was administered to 6 parkinsonians who developed early and late complications of levodopa therapy in our clinic. Some of these complications were well controlled by enteric coated levodopa, which seemed to prove that at least part of the problems of levodopa treatment are of peripheral origin. Role of enteric coated levodopa in medical management of parkinsonism is discussed.